CEREBYX
Fosphenytoin Sodium
- Strength
- 50 mg/mL
- Form
- Injection, Solution
- Class
- Anti-epileptic Agent
Pfizer Laboratories Div Pfizer Inc
Not stocked by us — reference only
Listed by GLENMARK PHARMACEUTICALS INC., USA
| Dosage form | Injection, Solution |
|---|---|
| Route | Intramuscular, Intravenous |
| Drug class | Anti-epileptic Agent |
| Approval route | ANDA — approved generic |
| NDC code | 68462-621 |
| FDA application | ANDA214926 |
| RxNorm concept | 1670195 |
| Package sizes listed | 1 |
| Marketed since | October 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Fosphenytoin Sodium
Pfizer Laboratories Div Pfizer Inc
Not stocked by us — reference only
Fosphenytoin Sodium
Pfizer Laboratories Div Pfizer Inc
Not stocked by us — reference only
Fosphenytoin Sodium
Pfizer Laboratories Div Pfizer Inc
Not stocked by us — reference only
FOSPHENYTOIN SODIUM
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
GLENMARK PHARMACEUTICALS INC., USA
Not stocked by us — reference only
GLENMARK PHARMACEUTICALS INC., USA
Not stocked by us — reference only
Amneal Pharmaceuticals LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.